ACHV
Price
$4.88
Change
+$0.33 (+7.25%)
Updated
Dec 3 closing price
Capitalization
259.78M
98 days until earnings call
Intraday BUY SELL Signals
RANI
Price
$1.61
Change
+$0.23 (+16.67%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
144.36M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs RANI

Header iconACHV vs RANI Comparison
Open Charts ACHV vs RANIBanner chart's image
Achieve Life Sciences
Price$4.88
Change+$0.33 (+7.25%)
Volume$746.17K
Capitalization259.78M
Rani Therapeutics Holdings
Price$1.61
Change+$0.23 (+16.67%)
Volume$18.99K
Capitalization144.36M
ACHV vs RANI Comparison Chart in %
ACHV
Daily Signal:
Gain/Loss:
RANI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACHV vs. RANI commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and RANI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ACHV: $4.56 vs. RANI: $1.39)
Brand notoriety: ACHV and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 19% vs. RANI: 7%
Market capitalization -- ACHV: $259.78M vs. RANI: $158.02M
ACHV [@Biotechnology] is valued at $259.78M. RANI’s [@Biotechnology] market capitalization is $158.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACHV and RANI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while RANI’s TA Score has 3 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • RANI’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RANI is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -0.65% price change this week, while RANI (@Biotechnology) price change was -13.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 12, 2026.

RANI is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($260M) has a higher market cap than RANI($144M). ACHV YTD gains are higher at: 29.545 vs. RANI (1.825). RANI (-47.11M) and ACHV (-49.25M) have comparable annual earnings (EBITDA) . ACHV has more cash in the bank: 55.4M vs. RANI (10.2M). ACHV has less debt than RANI: ACHV (9.96M) vs RANI (21.6M). RANI has higher revenues than ACHV: RANI (1.2M) vs ACHV (0).
ACHVRANIACHV / RANI
Capitalization260M144M181%
EBITDA-49.25M-47.11M105%
Gain YTD29.5451.8251,619%
P/E RatioN/AN/A-
Revenue01.2M-
Total Cash55.4M10.2M543%
Total Debt9.96M21.6M46%
FUNDAMENTALS RATINGS
ACHV: Fundamental Ratings
ACHV
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACHVRANI
RSI
ODDS (%)
Bearish Trend 7 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
87%
Bullish Trend 7 days ago
88%
Momentum
ODDS (%)
Bullish Trend 7 days ago
76%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
74%
Bearish Trend 7 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
83%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 7 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signal:
Gain/Loss:
RANI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDRDF91.09N/A
N/A
Pernod Ricard S.A.
MSEZ0.06N/A
N/A
Media Sentiment, Inc.
CNADF0.06N/A
N/A
CANADABIS CAP INC
HUTCY1.90N/A
N/A
Hutchison Telecommunications Hong Kong Holdings Ltd.
LVZPF5.22N/A
N/A
Livzon Pharmaceutical Group Inc.

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.94%
ALT - ACHV
46%
Loosely correlated
-3.65%
ATNM - ACHV
37%
Loosely correlated
N/A
PLRX - ACHV
36%
Loosely correlated
-2.61%
CLYM - ACHV
33%
Loosely correlated
-8.38%
ARTV - ACHV
33%
Loosely correlated
-3.75%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with KZR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-5.74%
KZR - RANI
54%
Loosely correlated
-0.48%
ARTV - RANI
42%
Loosely correlated
-3.75%
IRON - RANI
41%
Loosely correlated
-2.16%
ACHV - RANI
33%
Loosely correlated
-1.94%
ADVM - RANI
32%
Poorly correlated
-1.07%
More